Impact of headache on quality of life in a general population survey in France (GRIM2000 study)

被引:41
作者
Duru, G
Auray, JP
Gaudin, AF
Dartigues, JF
Henry, P
Lantéri-Minet, M
Lucas, C
Pradalier, A
Chazot, G
El Hasnaoui, A
机构
[1] Univ Lyon 1, F-69622 Villeurbanne, France
[2] Lab GlaxoSmithKline, Marly le Roi, France
[3] Univ Bordeaux 2, F-33076 Bordeaux, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Louis Pasteur, Nice, France
[6] Hop Roger Salengro, Lille, France
[7] Hop Neurol, F-69394 Lyon, France
[8] Hop Louis Mourier, F-92701 Colombes, France
来源
HEADACHE | 2004年 / 44卷 / 06期
关键词
migraine; quality of life; headache; biometrics;
D O I
10.1111/j.1526-4610.2004.446005.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives.-The objectives of this study were to determine the impact of headache on health-related quality of life in a nationwide sample of the French general population using a disease-specific measure, the Qualite de Vie et Migraine (QVM), to compare quality of life in subjects reporting different headache to types, and to evaluate the relationship between quality of life and severity, frequency, associated disability, and treatment responsiveness of headaches. Methods.-The QVM questionnaire was included within a large epidemiological survey of 1486 headache sufferers. Diagnosis was assigned retrospectively using an algorithm based on the International Headache Society classification. Headache severity was assessed with the MIGSEV scale and disability with the MIDAS scale. Results.-The mean global QVM score in the sample was 80.2. Quality of life was poorer in subjects with chronic daily headache (QVM score: 66.2) than in those with migraine (QVM score: 76.7), while those with other forms of episodic headache had the best quality of life (QVM score: 91.7). Quality-of-life scores were correlated with frequency, severity, disability, and treatment resistance of headaches (P < .001). Conclusion.-The QVM scale is a sensitive tool to measure health-related quality of life in headache sufferers in the general population.
引用
收藏
页码:571 / 580
页数:10
相关论文
共 27 条
[1]
BOUREAU F, 2005, EUR NEUROL, V35, P364
[2]
Use of health-related quality of life in prescribing research. Part 1: why evaluate health-related quality of life? [J].
Calvert, MJ ;
Freemantle, N .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (06) :513-521
[3]
Assessing the impact of migraine [J].
Dowson, AJ .
CURRENT MEDICAL RESEARCH AND OPINION, 2001, 17 (04) :298-309
[4]
Assessing the severity of migraine: Development of the MIGSEV scale [J].
El Hasnaoui, A ;
Vray, M ;
Richard, A ;
Nachit-Ouinekh, F ;
Boureau, F .
HEADACHE, 2003, 43 (06) :628-635
[5]
Quality of life in chronic daily headache -: A study in a general population [J].
Guitera, V ;
Muñoz, P ;
Castillo, J ;
Pascual, J .
NEUROLOGY, 2002, 58 (07) :1062-1065
[6]
GUYATT GH, 1986, CAN MED ASSOC J, V134, P889
[7]
DEVELOPMENT OF A BRIEF 24-HOUR MIGRAINE-SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE [J].
HARTMAIER, SL ;
SANTANELLO, NC ;
EPSTEIN, RS ;
SILBERSTEIN, SD .
HEADACHE, 1995, 35 (06) :320-329
[8]
Prevalence and clinical characteristics of migraine in France [J].
Henry, P ;
Auray, JP ;
Gaudin, AF ;
Dartigues, JF ;
Duru, G ;
Lantéri-Minet, M ;
Lucas, C ;
Pradalier, A ;
Chazot, G ;
El Hasnaoui, A .
NEUROLOGY, 2002, 59 (02) :232-237
[9]
SHORT FORM-36 (SF-36) HEALTH SURVEY QUESTIONNAIRE - NORMATIVE DATA FOR ADULTS OF WORKING AGE [J].
JENKINSON, C ;
COULTER, A ;
WRIGHT, L .
BRITISH MEDICAL JOURNAL, 1993, 306 (6890) :1437-1440
[10]
Jenkinson C, 1998, HLTH STATUS MEASUREM